Dofetilide, a new class III antiarrhythmic drug reduces hospital admissions for congestive heart failure — secondary endpoints of the DIAMOND-CHF study

✍ Scribed by L. Kaber

• Book ID: 118589520
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 175 KB
• Volume: 31
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(98)80798-5